Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Gonadotropins, including follicle-stimulating hormone (FSH), luteinizing hormone (LH), and human chorionic gonadotropin (hCG), are a family of heterodimeric glycoprotein hormones that play a fundamental role in the regulation of vertebrate reproduction [8, 14]. These hormones exert their biological effects by binding to specific G protein-coupled receptors (GPCRs): the follicle-stimulating hormone receptor (FSHR) and the luteinizing hormone/choriogonadotropin receptor (LHCGR) [1, 9]. In the ovaries, these interactions stimulate folliculogenesis, ovulation, and the production of estrogen and progesterone, while in the testes, they regulate spermatogenesis and testosterone synthesis [2, 10]. Clinical applications of gonadotropins and their analogs are extensive, primarily focusing on the treatment of infertility through ovulation induction and assisted reproductive technologies [7, 12]. Additionally, the gonadotropin signaling axis is a target for managing conditions such as polycystic ovary syndrome (PCOS), hypogonadism, and certain hormone-sensitive malignancies like prostate and ovarian cancer [4, 16]. Safety considerations in therapeutic use include the risk of ovarian hyperstimulation syndrome (OHSS) and multiple gestations [14, 17].
Agonism of the follicle-stimulating hormone receptor (FSHR) and the luteinizing hormone/choriogonadotropin receptor (LHCGR) to stimulate gametogenesis and steroidogenesis; modulation of the hypothalamic-pituitary-gonadal axis via GnRH analogs to indirectly regulate gonadotropin levels [7, 16].
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Gonadotropins and their receptors (Gn/GnR).